Long Term Open Follow-up With H376/95 vs. Warfarin

Terminated

Phase 2 Results N/A

Eligibility Criteria

Inclusion Criteria

- Signed informed consent.
- Completion of the study SH-TPA-0002, history of chronic atrial fibrillation (i.e. rapidly beating heart), at least one risk factor for stroke (e.g. high blood pressure, age over 65, previous stroke or similar attack, diabetes or coronary heart disease)

Exclusion Criteria

- Conditions associated with increased risk of bleeding, renal impairment, known active liver disease or liver insufficiency